Rob Christiaan van Wijk
I believe that the open questions in translational pharmacology can only be answered when state-of-the-art science from all relevant disciplines is integrated; both experimentally and computationally. This is why I see the value in collaborating across disciplines, which I also very much enjoy. Ideally, experiments are designed with the computational analysis in mind, and subsequent results are interpreted with the experimentalist's expertise. My (virtual) door is always open to discuss!
Keywords: pharmacology preclinical translational research pharmacokinetics pharmacodynamics tuberculosis infectious diseases clinical research experimental computational
Dr. Rob C. van Wijk received his Ph.D degree in Systems Pharmacology (systems biomedicine and pharmacology group) in 2020 from Leiden University, Netherlands. He is a postdoctoral researcher in pharmacometrics at the Department of Pharmaceutical Biosciences, Uppsala University, Sweden. His research is on translational pharmacology and predicting drug efficacy and safety from the preclinical to the clinical context, with a focus on integrating experimental and computational innovative methods.
Please contact the directory administrator for the organization (department or similar) to correct possible errors in the information.